BridgeMD
New treatment option for Esophageal Cancer
Official title Fluorescence Image Guided Foregut Surgery
ClinicalTrials.gov ID: NCT04734821
What this study is testing
- What it's testing
- A high number of resected lymph nodes is an independent prognostic factor for improved survival after esophagectomy or gastrectomy for cancer. The quality of the lymphadenectomy is operator-dependent, as is the evaluation of the vascularization of the digestive structures that are anastomosed to restore digestive continuity after esophago-gastric resection.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Man or woman over 18 years old.
- Patient with resectable primitive esophageal or gastric cancer confirmed by biopsy without distant metastases
- Patient with no contraindications to anaesthesia and performance of esophageal and/or gastric surgery
- Patient able to receive and understand information related to the study and give written informed consent.
- Patient affiliated to the French social security system.
You likely can't join if
- Patient undergoing emergency surgery (hemorrhage, occlusion or perforation).
- Presence of distant metastasis
- Patient at risk of allergy to indocyanine green or to other fluorescent compounds
- Pregnant or lactating patient.
- Patient in exclusion period (determined by a previous or a current study).
- Patient under the protection of justice.
See the full eligibility criteria
- Man or woman over 18 years old.
- Patient with resectable primitive esophageal or gastric cancer confirmed by biopsy without distant metastases
- Patient with no contraindications to anaesthesia and performance of esophageal and/or gastric surgery
- Patient able to receive and understand information related to the study and give written informed consent.
- Patient affiliated to the French social security system.
- Patient undergoing emergency surgery (hemorrhage, occlusion or perforation).
- Presence of distant metastasis
- Patient at risk of allergy to indocyanine green or to other fluorescent compounds
- Pregnant or lactating patient.
- Patient in exclusion period (determined by a previous or a current study).
- Patient under the protection of justice.
- Patient under guardianship or trusteeship.
- Patient deprived of liberty
The study team makes the final eligibility decision.
Where it's taking place
- Strasbourg, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Strasbourg, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.